Anti-MRSA agent 9
Anti-MRSA agent 9 (compound 39) exhibits antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) isolated from clinical samples, with a minimum inhibitory concentration (MIC) of 1 μg/ml. Additionally, Anti-MRSA agent 9 demonstrates anti-MRSA efficacy in vivo.
Product Specifications
Field of Research
Infectious Disease & Virology, Neuroscience
Molecular Formula
C39H44BrCl2N2O6P
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6251578-01 0.1 mL
CD45 (CD45 Antigen, B220, GP180, Leukocyte Common Antigen, LCA, L-CA, LY5, LY-5, Protein Tyrosine Phosphatase Receptor Type C, Protein Tyrosine Phosphatase Receptor Type C Polypeptide, PTPRC, T200, T200 Glycoprotein) (PE)
Sign In for Pricing
View Details MBS6251578-02 5x 0.1 mL
CD45 (CD45 Antigen, B220, GP180, Leukocyte Common Antigen, LCA, L-CA, LY5, LY-5, Protein Tyrosine Phosphatase Receptor Type C, Protein Tyrosine Phosphatase Receptor Type C Polypeptide, PTPRC, T200, T200 Glycoprotein) (PE)
Sign In for Pricing
View Details 
041349-APC 200 µL
RYBP, NT (RYBP, DEDAF, YEAF1, RING1 and YY1-binding protein, Apoptin-associating protein 1, Death effector domain-associated factor, YY1 and E4TF1-associated factor 1) (APC) discontinued
Sign In for Pricing
View Details